the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction

Randomized Controlled Trial Studying the Ameliorating Effects of Kaempferol Emulgel on Female Arousal Disorder and Sexual Dysfunction

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06060691

Enrollment

Registered

2023-09-29

Start date

2023-09-20

Completion date

2024-02-01

Last updated

2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Sexual Dysfunction

Brief summary

The aim of this study is to evaluate the quality of sexual life of females with sexual interest or arousal disorder before and after accurate application of a formulated emulgel made from natural ingredients, including kaempferol as an API

Interventions

DRUGKaempferol

Kaempferol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

28 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Women between the ages of 28 and 45 * had regular periods and previous menstrual bleeding lasted between three and seven days

Exclusion criteria

* sensitivity to drug of therapy, * cancer, * autoimmune illness, * smoking or drinking, * liver disease, * irregular menstruation

Design outcomes

Primary

Measure	Time frame	Description
Female Sexual Function Index	two months	The FSFI comprises 19 questions of sexual function in six independent areas consisting of desire, arousal, lubrication, orgasm, sexual satisfaction , pain from sex.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026